Chodakewitz Jeffrey
SEC-identified person · CIK 1610876 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Schrodinger, Inc. SDGR | Director | filed 2020–2026 |
| Restorbio, Inc. TORC | Director | filed 2018–2026 |
| Praxis Precision Medicines, Inc. PRAX | Director | filed 2021–2026 |
| Tetraphase Pharmaceuticals INC TTPH | Director | filed 2014–2019 |
| Vertex Pharmaceuticals INC / MA VRTX | SVP GMDA, CMO | filed 2014–2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.